Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Products Clinical

Orlistat and quinine sulfate among 13 further price concessions

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed further concessionary prices for 13 items for October 2019 prescriptions.

  • Eliza Slawther

An initial nine price concessions for the month were announced on October 22.

Drug
Strength
Form
Price
Desmopressin
200 micrograms
tablets (30)
£19.66
Hydroxyzine
10mg
tablets (84)
£2.95
Indoramin
20mg
tablets (60)
£11.45
Irbesartan
300mg
tablets (28)
£5.98
Levetiracetam
250mg
tablets (60)
£4.78
Meloxicam
15mg
tablets (30)
£3.13
Meloxicam
7.5mg
tablets (30)
£1.50
Mirtazapine
30mg
tablets (28)
£2.25
Orlistat
120mg
capsules (84)
£28.77
Oxytetracycline
250mg
tablets (28)
£1.80
Pizotifen
1.5mg
tablets (28)
£7.95
Quinine sulfate
200mg
tablets (28)
£3.20
Tizanidine
2mg
tablets (120)
£14.95
Table

View full table

Do these prices reflect the ones you have paid in October so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Products Clinical
Latest News & Analysis

Electronic prescription service ‘approved’ for rollout across Wales

‘New normal’ of medicine shortages a ‘significant burden on pharmacists’

Covert surveillance: GPhC may abandon ‘never used’ spying powers

Extra £9m cash injection for growing Glasgow digital pharmacy Phlo

See All
UsernamePublicRestriction

Register

CD006163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By